TD Asset Management
NTLA icon

TD Asset Management’s Intellia Therapeutics NTLA Stock Holding History

TD Asset Management’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,692
Closed -$844K – 1406
2024
Q1 		$844K Hold
30,692
– – ﹤0.01% 1202
2023
Q4 		$936K Sell
30,692
-18,200
-37% -$523K ﹤0.01% 1189
2023
Q3 		$1.55M Buy
48,892
+24,446
+100% +$948K ﹤0.01% 1030
2023
Q2 		$997K Sell
24,446
-5,325
-18% -$216K ﹤0.01% 1133
2023
Q1 		$1.11M Sell
29,771
-19,678
-40% -$772K ﹤0.01% 1111
2022
Q4 		$1.73M Buy
49,449
+4,178
+9% +$199K ﹤0.01% 1031
2022
Q3 		$2.5M Buy
45,271
+394
+0.9% +$24.4K ﹤0.01% 931
2022
Q2 		$2.32M Sell
44,877
-6,418
-13% -$326K ﹤0.01% 966
2022
Q1 		$3.73M Sell
51,295
-6,254
-11% -$530K ﹤0.01% 897
2021
Q4 		$6.8M Buy
57,549
+2,719
+5% +$341K 0.01% 787
2021
Q3 		$7.36M Sell
54,830
-1,100
-2% -$167K 0.01% 728
2021
Q2 		$7.93M Buy
55,930
+4,451
+9% +$347K 0.01% 712
2021
Q1 		$4.13M Buy
51,479
+5,250
+11% +$352K ﹤0.01% 884
2020
Q4 		$2.52M Buy
46,229
+7,372
+19% +$268K ﹤0.01% 975
2020
Q3 		$772K Buy
38,857
+4,300
+12% +$89.7K ﹤0.01% 1136
2020
Q2 		$726K Buy
+34,557
New +$587K ﹤0.01% 1135

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TD Asset Management's NTLA Position: Q2 2024 in Review

TD Asset Management sold out of Intellia Therapeutics (NTLA) in Q2 2024, closing a stake of 30,692 shares — an estimated $844K sold.

TD Asset Management first reported a position in NTLA in Q2 2020 and held it in 16 quarters. The position peaked at $7.93M in Q2 2021. 290 funds tracked by Wall St. Rank hold NTLA as of Q2 2024.

  • TD Asset Management reported no remaining Intellia Therapeutics position as of Q2 2024 after selling out during the quarter.
  • TD Asset Management sold 30,692 Intellia Therapeutics shares in Q2 2024, an estimated $844K.
  • TD Asset Management first reported a position in Intellia Therapeutics in Q2 2020 and held it in 16 quarters.
  • TD Asset Management's Intellia Therapeutics position peaked at $7.93M in Q2 2021.
  • 290 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2024.

Based on TD Asset Management's 13F filing for Q2 2024, filed 2 Aug 2024.